Target Price | $270.20 |
Price | $202.32 |
Potential | 33.55% |
Number of Estimates | 31 |
31 Analysts have issued a price target Atlassian 2026 . The average Atlassian target price is $270.20. This is 33.55% higher than the current stock price. The highest price target is $441.00 117.97% , the lowest is $217.15 7.33% . | |
A rating was issued by 37 analysts: 28 Analysts recommend Atlassian to buy, 9 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Atlassian stock has an average upside potential 2026 of 33.55% . Most analysts recommend the Atlassian stock at Purchase. |
34 Analysts have issued a sales forecast Atlassian 2025 . The average Atlassian sales estimate is $5.3b . This is 6.62% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $5.5b 10.59% , the lowest is $5.1b 2.29% .
This results in the following potential growth metrics:
2024 | $4.4b | 23.31% |
---|---|---|
2025 | $5.3b | 21.39% |
2026 | $6.3b | 19.03% |
2027 | $7.5b | 19.12% |
2028 | $8.8b | 16.80% |
2029 | $10.2b | 16.39% |
2030 | $11.9b | 16.92% |
2031 | $13.7b | 15.20% |
2032 | $15.7b | 14.36% |
13 Analysts have issued an Atlassian EBITDA forecast 2025. The average Atlassian EBITDA estimate is $1.3b . This is 973.81% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $1.4b 1,019.97% , the lowest is $1.2b 910.74% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $-104m | 56.18% |
---|---|---|
2025 | $1.3b | 1,388.34% |
2026 | $1.6b | 22.25% |
2027 | $2.1b | 24.77% |
2028 | $2.1b | 4.29% |
2029 | $2.5b | 16.37% |
2024 | -2.39% | 64.46% |
---|---|---|
2025 | 25.40% | 1,161.24% |
2026 | 26.09% | 2.72% |
2027 | 27.33% | 4.75% |
2028 | 24.40% | 10.72% |
2029 | 24.40% | 0.00% |
33 Atlassian Analysts have issued a net profit forecast 2025. The average Atlassian net profit estimate is $955m . This is 322.21% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $1.1b 345.00% , the lowest is $895m 308.26% .
This results in the following potential growth metrics and future Net Margins:
2024 | $-301m | 38.26% |
---|---|---|
2025 | $955m | 417.73% |
2026 | $1.1b | 19.01% |
2027 | $1.4b | 22.47% |
2028 | $1.6b | 15.21% |
2029 | $2.0b | 21.96% |
2030 | $2.8b | 43.31% |
2031 | $3.5b | 25.48% |
2032 | $4.4b | 23.97% |
2024 | -6.89% | 49.93% |
---|---|---|
2025 | 18.05% | 361.79% |
2026 | 18.04% | 0.06% |
2027 | 18.55% | 2.83% |
2028 | 18.30% | 1.35% |
2029 | 19.17% | 4.75% |
2030 | 23.50% | 22.59% |
2031 | 25.60% | 8.94% |
2032 | 27.75% | 8.40% |
33 Analysts have issued a Atlassian forecast for earnings per share. The average Atlassian EPS is $3.63 . This is 322.70% higher than earnings per share in the financial year 2024. The highest EPS forecast is $4.00 345.40% , the lowest is $3.40 308.59% .
This results in the following potential growth metrics and future valuations:
2024 | $-1.16 | 38.95% |
---|---|---|
2025 | $3.63 | 412.93% |
2026 | $4.32 | 19.01% |
2027 | $5.29 | 22.45% |
2028 | $6.09 | 15.12% |
2029 | $7.43 | 22.00% |
2030 | $10.65 | 43.34% |
2031 | $13.36 | 25.45% |
2032 | $16.56 | 23.95% |
Current | -124.12 | 53.39% |
---|---|---|
2025 | 55.76 | 144.92% |
2026 | 46.85 | 15.98% |
2027 | 38.26 | 18.34% |
2028 | 33.21 | 13.20% |
2029 | 27.23 | 18.01% |
2030 | 19.00 | 30.22% |
2031 | 15.14 | 20.32% |
2032 | 12.21 | 19.35% |
Based on analysts' sales estimates for 2025, the Atlassian stock is valued at an EV/Sales of 9.69 and an P/S ratio of 10.07 .
This results in the following potential growth metrics and future valuations:
Current | 10.33 | 4.55% |
---|---|---|
2025 | 9.69 | 6.19% |
2026 | 8.14 | 15.99% |
2027 | 6.83 | 16.05% |
2028 | 5.85 | 14.38% |
2029 | 5.03 | 14.08% |
2030 | 4.30 | 14.47% |
2031 | 3.73 | 13.19% |
2032 | 3.26 | 12.56% |
Current | 10.73 | 5.74% |
---|---|---|
2025 | 10.07 | 6.21% |
2026 | 8.46 | 15.99% |
2027 | 7.10 | 16.05% |
2028 | 6.08 | 14.38% |
2029 | 5.22 | 14.08% |
2030 | 4.47 | 14.47% |
2031 | 3.88 | 13.19% |
2032 | 3.39 | 12.56% |
Analyst | Rating | Action | Date |
---|---|---|---|
Mizuho |
Outperform
➜
Outperform
|
Unchanged | Jun 12 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | May 05 2025 |
Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | May 02 2025 |
Stephens & Co. |
Equal-Weight
➜
Equal-Weight
|
Unchanged | May 02 2025 |
Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | May 02 2025 |
Canaccord Genuity |
Buy
➜
Buy
|
Unchanged | May 02 2025 |
Macquarie |
Outperform
➜
Outperform
|
Unchanged | May 02 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Mizuho:
Outperform
➜
Outperform
|
Jun 12 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
May 05 2025 |
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
May 02 2025 |
Unchanged
Stephens & Co.:
Equal-Weight
➜
Equal-Weight
|
May 02 2025 |
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
May 02 2025 |
Unchanged
Canaccord Genuity:
Buy
➜
Buy
|
May 02 2025 |
Unchanged
Macquarie:
Outperform
➜
Outperform
|
May 02 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.